补体因子I罕见变异导致血浆FI水平降低并增加年龄相关性黄斑变性风险
本研究在276例AMD患者和205例老年对照中验证CFI罕见变异与血浆FI水平及AMD风险的关联。携带罕见CFI变异的AMD患者FI中位数(28.3 µg/mL)显著低于无变异AMD患者(38.8 µg/mL,P=0.004)及对照组。FI水平降低与AMD风险显著相关(早或晚期AMD OR 12.05,P=0.03)。
要点
- 携带罕见CFI变异的AMD患者血浆FI中位数28.3 µg/mL,显著低于无变异AMD患者和对照组。
- FI水平降低与AMD风险相关:早或晚期AMD OR 12.05(P=0.03),早期AMD OR 30.3(P=0.02),晚期AMD OR 10.64(P<0.01)。
- 房水与全身循环FI浓度梯度约286倍,提示Bruch膜对FI不通透,影响FI替代治疗。
核心结论
- CFI罕见变异导致全身FI水平降低,与AMD强关联。
研究设计与样本
- 独立队列研究,纳入276例AMD患者和205例老年对照,用夹心ELISA测FI水平,用SNP分型和Sanger测序评估遗传变异。
主要发现
- AMD伴罕见CFI变异者FI中位数28.3 µg/mL,低于AMD无变异者38.8 µg/mL(P=0.004)、对照有变异者41.7 µg/mL(P=0.0085)和对照无变异者41.5 µg/mL(P<0.0001)。
- 多元回归显示FI水平降低与AMD风险相关:早或晚期AMD OR 12.05(P=0.03),早期AMD OR 30.3(P=0.02),晚期AMD OR 10.64(P<0.01)。
- 房水与全身循环间FI浓度梯度约286倍。
关键数值与推荐
- AMD伴罕见CFI变异者FI中位数28.3 µg/mL。
- AMD无罕见CFI变异者FI中位数38.8 µg/mL(P=0.004)。
- 对照伴罕见CFI变异者FI中位数41.7 µg/mL(P=0.0085)。
- 对照无罕见CFI变异者FI中位数41.5 µg/mL(P<0.0001)。
- FI水平降低与AMD风险:早或晚期AMD OR 12.05(P=0.03),早期AMD OR 30.3(P=0.02),晚期AMD OR 10.64(P<0.01)。
临床怎么用
- 对AMD患者可考虑检测CFI罕见变异及血浆FI水平以评估风险。
- Bruch膜对FI不通透,FI替代治疗需考虑眼内递送策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Rare genetic variants in complement factor I (CFI) that cause low systemic levels of the protein (FI) have been reported as a strong risk factor for advanced age-related macular degeneration (AMD). This study set out to replicate these findings. METHODS: FI levels were measured by sandwich ELISA in an independent cohort of 276 patients with AMD and 205 elderly controls. Single-nucleotide polymorphism genotyping and Sanger sequencing were used to assess genetic variability. RESULTS: The median FI level was significantly lower in those individuals with AMD and a rare CFI variant (28.3 µg/mL) compared to those with AMD without a rare CFI variant (38.8 µg/mL, P = 0.004) or the control population with (41.7 µg/mL, P = 0.0085) or without (41.5 µg/mL, P < 0.0001) a rare CFI variant. Thirty-six percent of patients with AMD with a rare CFI variant had levels below the fifth percentile, compared to 6% in controls with CFI variants. Multiple regression analyses revealed a decreased FI level associated with a rare CFI variant was a risk factor for AMD (early or late AMD: odds ratio [OR] 12.05, P = 0.03; early AMD: OR 30.3, P = 0.02; late AMD: OR 10.64, P < 0.01). Additionally, measurement of FI in aqueous humor revealed a large FI concentration gradient between systemic circulation and the eye (∼286-fold). CONCLUSIONS: Rare genetic variants in CFI causing low systemic FI levels are strongly associated with AMD. The impermeability of the Bruch's membrane to FI will have implications for therapeutic replacement of FI in individuals with CFI variants and low FI levels at risk of AMD.
引用
- Hallam TM, Marchbank KJ, Harris CL, et al. Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2020. PMID: 32516404. doi:10.1167/iovs.61.6.18
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。